GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 395, 709â733 (2020).
Dumanski, S. M. & Ahmed, S. B. Fertility and reproductive care in chronic kidney disease. J. Nephrol. 32, 39â50 (2019).
Google ScholarÂ
Mills, K. T. et al. A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int. 88, 950â957 (2015).
Google ScholarÂ
Feig, D. S. Epidemiology and therapeutic strategies for women with preexisting diabetes in pregnancy: how far have we come? The 2021 Norbert Freinkel Award Lecture. Diabetes Care 45, 2484â2491 (2022).
Google ScholarÂ
Mackin, S. T. et al. Diabetes and pregnancy: national trends over a 15 year period. Diabetologia 61, 1081â1088 (2018).
Google ScholarÂ
Wang, M. C. et al. Trends in prepregnancy obesity and association with adverse pregnancy outcomes in the United States, 2013 to 2018. J. Am. Heart Assoc. 10, e020717 (2021).
Google ScholarÂ
Strauss, A. et al. Obesity in pregnant women: a 20-year analysis of the German experience. Eur. J. Clin. Nutr. 75, 1757â1763 (2021).
Google ScholarÂ
Poston, L. et al. Preconceptional and maternal obesity: epidemiology and health consequences. Lancet Diabetes Endocrinol. 4, 1025â1036 (2016).
Google ScholarÂ
Ananth, C. V. et al. Changes in the prevalence of chronic hypertension in pregnancy, United States, 1970 to 2010. Hypertension 74, 1089â1095 (2019).
Google ScholarÂ
Care of pregnant women. Boston Med. Surg. J. 166:292â293 (1912).
Jesudason, S. & Tong, A. The patient experience of kidney disease and pregnancy. Best. Pract. Res. Clin. Obstet. Gynaecol. 57, 77â88 (2019).
Google ScholarÂ
Ralston, E. R. et al. Exploring biopsychosocial correlates of pregnancy risk and pregnancy intention in women with chronic kidney disease. J. Nephrol. 36, 1361â1372 (2023).
Google ScholarÂ
Pregnancy and renal disease. Lancet. 2:801â802 (1975).
Mc Laughlin, L. et al. Feminizing care pathways: mixed-methods study of reproductive options, decision making, pregnancy, post-natal care and parenting amongst women with kidney disease. J. Adv. Nurs. 79, 3127â3146 (2023).
Google ScholarÂ
Garlanda, C., Bottazzi, B., Bastone, A. & Mantovani, A. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu. Rev. Immunol. 23, 337â366 (2005).
Google ScholarÂ
Camaioni A., Klinger F. G., Campagnolo L., Salustri A. The influence of pentraxin 3 on the ovarian function and its impact on fertility. Front. Immunol. 9, 2808 (2018).
Google ScholarÂ
Rojas, R., Clegg, D. J. & Palmer, B. F. Amenorrhea and estrogen disorders in kidney disease. Semin. Nephrol. 41, 126â132 (2021).
Google ScholarÂ
Wiles, K. et al. Anti-MĂźllerian hormone concentrations in women with chronic kidney disease. Clin. Kidney J. 14, 537â542 (2021).
Google ScholarÂ
Gupta, J. et al. Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC. Clin. J. Am. Soc. Nephrol. 7, 1938â1946 (2012).
Google ScholarÂ
Holley, J. L., Schmidt, R. J., Bender, F. H., Dumler, F. & Schiff, M. Gynecologic and reproductive issues in women on dialysis. Am. J. Kidney Dis. 29, 685â690 (1997).
Google ScholarÂ
Hou, S. Pregnancy in chronic renal insufficiency and end-stage renal disease. Am. J. Kidney Dis. 33, 235â252 (1999).
Google ScholarÂ
Hewawasam, E. et al. Factors influencing fertility rates in Australian women receiving kidney replacement therapy: analysis of linked Australia and New Zealand Dialysis and Transplant Registry and perinatal data over 22âyears. Nephrol. Dial. Transpl. 37, 1152â1161 (2022).
Google ScholarÂ
Vrijlandt, W. A. L. et al. Prevalence of chronic kidney disease in women of reproductive age and observed birth rates. J. Nephrol. 36, 1341â1347 (2023).
Google ScholarÂ
Uldall, P. R., Kerr, D. N. & Tacchi, D. Sterility and cyclophosphamide. Lancet. 1, 693â694 (1972).
Google ScholarÂ
Gajjar, R., Miller, S. D., Meyers, K. E. & Ginsberg, J. P. Fertility preservation in patients receiving cyclophosphamide therapy for renal disease. Pediatr. Nephrol. 30, 1099â1106 (2015).
Google ScholarÂ
Kidney Disease: Improving Global Outcomes (KDIGO) glomerular diseases work group. KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int. 100, S1âS276 (2021).
Dines, V. A., Garovic, V. D., Parashuram, S., Cosio, F. G. & Kattah, A. G. Pregnancy, contraception, and menopause in advanced chronic kidney disease and kidney transplant. Womens Health Rep. 2, 488â496 (2021).
Rytz, C. L. et al. Menstrual abnormalities and reproductive lifespan in females with CKD: a systematic review and meta-analysis. Clin. J. Am. Soc. Nephrol. 17, 1742â1753 (2022).
Google ScholarÂ
Dines, V. A. & Garovic, V. D. Menopause and chronic kidney disease. Nat. Rev. Nephrol. 20, 4â5 (2023).
Google ScholarÂ
Vellanki, K. & Hou, S. Menopause in CKD. Am. J. Kidney Dis. 71, 710â719 (2018).
Google ScholarÂ
Iwase, A. et al. AntiâMĂźllerian hormone as a marker of ovarian reserve: what have we learned, and what should we know? Reprod. Med. Biol. 15, 127â136 (2015).
Google ScholarÂ
Seifer, D. B., Baker, V. L. & Leader, B. Age-specific serum anti-MĂźllerian hormone values for 17,120 women presenting to fertility centers within the United States. Fertil. Steril. 95, 747â750 (2011).
Google ScholarÂ
ĹenateĹ, E. et al. Serum anti-MĂźllerian hormone levels are lower in reproductive-age women with Crohnâs disease compared to healthy control women. J. Crohns Colitis 7, e29âe34 (2013).
Google ScholarÂ
Cakmak, E., Karakus, S., Demirpence, O. & Coskun, B. D. Ovarian reserve assessment in celiac patients of reproductive age. Med. Sci. Monit. Int. Med. J. Exp. Clin. Res. 24, 1152â1157 (2018).
Google ScholarÂ
Karampatou, A. et al. Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV. J. Hepatol. (2017).
Aydogan Mathyk, B., Aslan Cetin, B., Bilici, S., Fasse, J. & Avci, P. Evaluation of ovarian reserve in women with psoriasis. Gynecol. Endocrinol. 35, 608â611 (2019).
Google ScholarÂ
Lin, C. et al. The value of anti-MĂźllerian hormone in the prediction of spontaneous pregnancy: a systematic review and meta-analysis. Front. Endocrinol. 12, 695157 (2021).
Google ScholarÂ
Steiner, A. Z. et al. Association between biomarkers of ovarian reserve and infertility among older women of reproductive age. JAMA 318, 1367â1376 (2017).
Google ScholarÂ
Venturella, R. et al. OvAge: a new methodology to quantify ovarian reserve combining clinical, biochemical and 3D-ultrasonographic parameters. J. Ovarian Res. 8, 21 (2015).
Google ScholarÂ
Ding, T. et al. Assessment and quantification of ovarian reserve on the basis of machine learning models. Front. Endocrinol. 14, 1087429 (2023).
Google ScholarÂ
Shah, W. et al. The molecular mechanism of sex hormones on Sertoli cell development and proliferation. Front. Endocrinol. 12, 648141 (2021).
Google ScholarÂ
Bhattacharya, I. et al. Testosterone augments FSH signaling by upregulating the expression and activity of FSH-Receptor in Pubertal Primate Sertoli cells. Mol. Cell Endocrinol. 482, 70â80 (2019).
Google ScholarÂ
Scarabelli, L., Caviglia, D., Bottazzi, C. & Palmero, S. Prolactin effect on pre-pubertal Sertoli cell proliferation and metabolism. J. Endocrinol. Invest. 26, 718â722 (2003).
Google ScholarÂ
Guillaumot, P., Tabone, E. & Benahmed, M. Sertoli cells as potential targets of prolactin action in the testis. Mol. Cell Endocrinol. 122, 199â206 (1996).
Google ScholarÂ
Petersen, C. & Soder, O. The Sertoli cell â a hormonal target and âsuperâ nurse for germ cells that determines testicular size. Horm. Res. 66, 153â161 (2006).
Google ScholarÂ
Palmer, B. F. Sexual dysfunction in men and women with chronic kidney disease and end-stage kidney disease. Adv. Ren. Replace. Ther. 10, 48â60 (2003).
Google ScholarÂ
Eckersten, D., Giwercman, A. & Christensson, A. Male patients with terminal renal failure exhibit low serum levels of antimĂźllerian hormone. Asian J. Androl. 17, 149â153 (2015).
Google ScholarÂ
Gill-Sharma, M. K. Prolactin and male fertility: the long and short feedback regulation. Int. J. Endocrinol. 2009, 687259 (2009).
Google ScholarÂ
Romejko, K., Rymarz, A., Sadownik, H. & Niemczyk, S. Testosterone deficiency as one of the major endocrine disorders in chronic kidney disease. Nutrients 14, 3438 (2022).
Google ScholarÂ
Khurana, K. K. et al. Serum testosterone levels and mortality in men with CKD stages 3â4. Am. J. Kidney Dis. 64, 367â374 (2014).
Google ScholarÂ
Fantus, R. J. et al. Serum total testosterone and premature mortality among men in the USA. Eur. Urol. Open. Sci. 29, 89â92 (2021).
Google ScholarÂ
Ros, S. & Carrero, J. J. Endocrine alterations and cardiovascular risk in CKD: is there a link? Nefrol. Engl. Ed. 33, 181â187 (2013).
Guay, A., Seftel, A. D. & Traish, A. Hypogonadism in men with erectile dysfunction may be related to a host of chronic illnesses. Int. J. Impot. Res. 22, 9â19 (2010).
Google ScholarÂ
Bass, A. et al. The impact of nocturnal hemodialysis on sexual function. BMC Nephrol. 13, 67 (2012).
Google ScholarÂ
Van Eps, C. et al. Changes in serum prolactin, sex hormones and thyroid function with alternate nightly nocturnal home haemodialysis. Nephrology 17, 42â47 (2012).
Google ScholarÂ
Kuczera, P., WiÄcek, A. & Adamczak, M. Impaired fertility in women and men with chronic kidney disease. Adv. Clin. Exp. Med. 31, 187â195 (2022).
Google ScholarÂ
Eckersten, D., Giwercman, A., PihlsgĂĽrd, M., Bruun, L. & Christensson, A. Impact of kidney transplantation on reproductive hormone levels in males: a longitudinal study. Nephron 138, 192â201 (2017).
Google ScholarÂ
Zhang, Y. et al. Kidney transplantation improve semen quality in patients with dialysis: a systematic review and meta-analysis. Andrologia 53, e14158 (2021).
Google ScholarÂ
Lehtihet, M. & Hylander, B. Semen quality in men with chronic kidney disease and its correlation with chronic kidney disease stages. Andrologia 47, 1103â1108 (2015).
Google ScholarÂ
Boitrelle, F. et al. The sixth edition of the WHO manual for human semen analysis: a critical review and SWOT analysis. Life 11, 1368 (2021).
Google ScholarÂ
Bonde, J. P. et al. Relation between semen quality and fertility: a population-based study of 430 first-pregnancy planners. Lancet Lond. Engl. 352, 1172â1177 (1998).
Google ScholarÂ
Slama, R. et al. Time to pregnancy and semen parameters: a cross-sectional study among fertile couples from four European cities. Hum. Reprod. Oxf. Engl. 17, 503â515 (2002).
Google ScholarÂ
BjĂśrndahl, L. A paradigmatic shift in the care of male factor infertility: how can the recommendations for basic semen examination in the sixth edition of the WHO manual and the ISO 23162:2021 standard help? Reprod. Biomed. Online 45, 731â736 (2022).
Google ScholarÂ
Esteves, S. C. Evolution of the World Health Organization semen analysis manual: where are we? Nat. Rev. Urol. 19, 439â446 (2022).
Google ScholarÂ
Haddock, L. et al. Sperm DNA fragmentation is a novel biomarker for early pregnancy loss. Reprod. Biomed. Online 42, 175â184 (2021).
Google ScholarÂ
Dai, Y. Relationship among traditional semen parameters, sperm DNA fragmentation, and unexplained recurrent miscarriage: a systematic review and meta-analysis. Front. Endocrinol. 12, 802632 (2021).
Google ScholarÂ
Borges, E. et al. Sperm DNA fragmentation is correlated with poor embryo development, lower implantation rate, and higher miscarriage rate in reproductive cycles of non-male factor infertility. Fertil. Steril. 112, 483â490 (2019).
Google ScholarÂ
Homa, S. T. et al. A comparison between two assays for measuring seminal oxidative stress and their relationship with sperm DNA fragmentation and semen parameters. Genes 10, 236 (2019).
Google ScholarÂ
Aitken, R. J. & De Iuliis, G. N. On the possible origins of DNA damage in human spermatozoa. Mol. Hum. Reprod. 16, 3â13 (2010).
Google ScholarÂ
Duni, A., Liakopoulos, V., Roumeliotis, S., Peschos, D. & Dounousi, E. Oxidative stress in the pathogenesis and evolution of chronic kidney disease: untangling Ariadneâs thread. Int. J. Mol. Sci. 20, 3711 (2019).
Google ScholarÂ
Javadneia, A. et al. Sperm DNA damage before and after kidney transplantation. Nephro-Urol. Mon. 11, e86990 (2019).
Colombijn, J. M. et al. Antioxidants for adults with chronic kidney disease. Cochrane Database Syst. Rev. 11, CD008176 (2023).
Google ScholarÂ
de Ligny, W. et al. Antioxidants for male subfertility. Cochrane Database Syst. Rev. 5, CD007411 (2022).
Google ScholarÂ
Pyrgidis, N. et al. Prevalence of erectile dysfunction in patients with end-stage renal disease: a systematic review and meta-analysis. J. Sex. Med. 18, 113â120 (2021).
Google ScholarÂ
Edey, M. M. Male sexual dysfunction and chronic kidney disease. Front. Med. 4, 32 (2017).
Google ScholarÂ
Lotti, F. & Maggi, M. Sexual dysfunction and male infertility. Nat. Rev. Urol. 15, 287â307 (2018).
Google ScholarÂ
Vecchio, M. et al. Interventions for treating sexual dysfunction in patients with chronic kidney disease. Cochrane Database Syst. Rev. 8, CD007747 (2010).
Lundy, S. D. & Vij, S. C. Male infertility in renal failure and transplantation. Transl. Androl. Urol. 8, 173â181 (2019).
Google ScholarÂ
Mondal, S., Sinha Roy, P. P. & Pal, D. K. Sexual well-being and fertility in male renal transplant recipients: a study in a tertiary care centre. Urol. J. 89, 636â640 (2022).
Google ScholarÂ
Tainio, J. et al. Testicular function, semen quality, and fertility in young men after renal transplantation during childhood or adolescence. Transplantation 98, 987â993 (2014).
Google ScholarÂ
Bearak, J. et al. Unintended pregnancy and abortion by income, region, and the legal status of abortion: estimates from a comprehensive model for 1990â2019. Lancet Glob. Health 8, e1152âe1161 (2020).
Google ScholarÂ
Ghazizadeh, S. et al. Unwanted pregnancy among kidney transplant recipients in Iran. Transpl. Proc. 37, 3085â3086 (2005).
Google ScholarÂ
Lessan-Pezeshki, M. et al. Fertility and contraceptive issues after kidney transplantation in women. Transpl. Proc. 36, 1405â1406 (2004).
Google ScholarÂ
Shah, S., Christianson, A. L., Bumb, S. & Verma, P. Contraceptive use among women with kidney transplants in the United States. J. Nephrol. 35, 629â638 (2022).
Google ScholarÂ
Britton, L. Unintended pregnancy: a systematic review of contraception use and counseling in women with cancer. Clin. J. Oncol. Nurs. 21, 189â196 (2017).
Google ScholarÂ
Phillips-Bell, G. S., Sappenfield, W., Robbins, C. L. & Hernandez, L. Chronic diseases and use of contraception among women at risk of unintended pregnancy. J. Womens Health 25, 1262â1269 (2016).
Google ScholarÂ
Harris, M. L. et al. Patterns of contraceptive use among young Australian women with chronic disease: findings from a prospective cohort study. Reprod. Health 19, 111 (2022).
Google ScholarÂ
Baker, R. J., Mark, P. B., Patel, R. K., Stevens, K. K. & Palmer, N. Renal association clinical practice guideline in post-operative care in the kidney transplant recipient. BMC Nephrol. 18, 174 (2017).
Google ScholarÂ
Wiles, K. et al. Clinical practice guideline on pregnancy and renal disease. BMC Nephrol. 20, 401 (2019).
Google ScholarÂ
Brynhildsen, J. Combined hormonal contraceptives: prescribing patterns, compliance, and benefits versus risks. Ther. Adv. Drug. Saf. 5, 201â213 (2014).
Google ScholarÂ
Attini, R. et al. Contraception in chronic kidney disease: a best practice position statement by the Kidney and Pregnancy Group of the Italian Society of Nephrology. J. Nephrol. 33, 1343â1359 (2020).
Google ScholarÂ
Browne, H., Manipalviratn, S. & Armstrong, A. Using an intrauterine device in immunocompromised women. Obstet. Gynecol. 112, 667â669 (2008).
Google ScholarÂ
Balbach, M. et al. On-demand male contraception via acute inhibition of soluble adenylyl cyclase. Nat. Commun. 14, 637 (2023).
Google ScholarÂ
Koilpillai, J. N., Nunan, E., Butler, L., Pinaffi, F. & Butcher, J. T. Reversible contraception in males: an obtainable target? Biology 13, 291 (2024).
Google ScholarÂ
Thirumalai, A. & Page, S. T. Recent developments in male contraception. Drugs 79, 11â20 (2019).
Google ScholarÂ
Trussell, J. Contraceptive failure in the United States. Contraception 83, 397â404 (2011).
Google ScholarÂ
Abbe, C. R., Page, S. T. & Thirumalai, A. Male contraception. Yale J. Biol. Med. 93, 603â613 (2020).
Google ScholarÂ
Berer, M. Abortion law and policy around the world. Health Hum. Rights 19, 13â27 (2017).
Google ScholarÂ
Qi, A. & Hladunewich, M. A. Nephrology and womenâs health post-Roe v. Wade: we must do better. Nat. Rev. Nephrol. 18, 741â742 (2022).
Google ScholarÂ
Rizzolo, K., Faucett, A. & Kendrick, J. Implications of antiabortion laws on patients with kidney disease in pregnancy. Clin. J. Am. Soc. Nephrol. 18, 276â278 (2023).
Google ScholarÂ
Robinson, G. E. et al. The mental and physical health impacts of overturning Roe v Wade. J. Nerv. Ment. Dis. 210, 891â893 (2022).
Google ScholarÂ
Piccoli, G. B. et al. The children of dialysis: live-born babies from on-dialysis mothers in Italy â an epidemiological perspective comparing dialysis, kidney transplantation and the overall population. Nephrol. Dial. Transpl. 29, 1578â1586 (2014).
Google ScholarÂ
Ahmed, S. B., Vitek, W. S. & Holley, J. L. Fertility, contraception, and novel reproductive technologies in chronic kidney disease. Semin. Nephrol. 37, 327â336 (2017).
Google ScholarÂ
Tangren, J., Nadel, M. & Hladunewich, M. A. Pregnancy and end-stage renal disease. Blood Purif. 45, 194â200 (2018).
Google ScholarÂ
Horsey K. The future of surrogacy: a review of current global trends and national landscapes. Reprod Biomed Online. 48, 103764.
Madej, A., Mazanowska, N., Cyganek, A., Pazik, J. & Pietrzak, B. Neonatal and maternal outcomes among women with glomerulonephritis. Am. J. Nephrol. 51, 534â541 (2020).
Google ScholarÂ
Sifontis, N. M. et al. Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus. Transplantation 82, 1698â1702 (2006).
Google ScholarÂ
Drugs and Lactation Database (LactMed). National Center for Biotechnology Information (2006).
Flint, J. et al. BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids. Rheumatol. Oxf. Engl. 55, 1693â1697 (2016).
Google ScholarÂ
Wallace, D. J., Gudsoorkar, V. S., Weisman, M. H. & Venuturupalli, S. R. New insights into mechanisms of therapeutic effects of antimalarial agents in SLE. Nat. Rev. Rheumatol. 8, 522â533 (2012).
Google ScholarÂ
Zemlickis, D. et al. Fetal outcome after in utero exposure to cancer chemotherapy. Arch. Intern. Med. 152, 573â576 (1992).
Google ScholarÂ
Boulay, H. et al. Maternal, foetal and child consequences of immunosuppressive drugs during pregnancy in women with organ transplant: a review. Clin. Kidney J. 14, 1871â1878 (2021).
Google ScholarÂ
Perrotta, K., Kiernan, E., Bandoli, G., Manaster, R. & Chambers, C. Pregnancy outcomes following maternal treatment with rituximab prior to or during pregnancy: a case series. Rheumatol. Adv. Pract. 5, rkaa074 (2021).
Google ScholarÂ
Kao, J. H. et al. Pregnancy outcomes in patients treated with belimumab: report from real-world experience. Semin. Arthritis Rheum. 51, 963â968 (2021).
Google ScholarÂ
FDA. Rapamune. (sirolimus) drug information sheet. https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/021083s006lbl.pdf.
Ponticelli, C. & Moroni, G. Fetal toxicity of immunosuppressive drugs in pregnancy. J. Clin. Med. 7, 552 (2018).
Google ScholarÂ
Tshering, S., Dorji, N., Youden, S. & Wangchuk, D. Maternal sirolimus therapy and fetal growth restriction. Arch. Clin. Cases 8, 19â24 (2021).
Google ScholarÂ
Lip, G. Y., Churchill, D., Beevers, M., Auckett, A. & Beevers, D. G. Angiotensin-converting-enzyme inhibitors in early pregnancy. Lancet. 350, 1446â1447 (1997).
Google ScholarÂ
Centers for Disease Control and Prevention (CDC). Postmarketing surveillance for angiotensin-converting enzyme inhibitor use during the first trimester of pregnancy â United States, Canada, and Israel, 1987â1995. MMWR Morb. Mortal. Wkly. Rep. 46, 240â242 (1997).
Bar, J., Hod, M. & Merlob, P. Angiotensin converting enzyme inhibitors use in the first trimester of pregnancy. Int. J. Risk Saf. Med. 10, 23â26 (1997).
Google ScholarÂ
Steffensen, F. H., Nielsen, G. L., Sørensen, H. T., Olesen, C. & Olsen, J. Pregnancy outcome with ACE-inhibitor use in early pregnancy. Lancet Lond. Engl. 351, 596 (1998).
Google ScholarÂ
Li, D. K., Yang, C., Andrade, S., Tavares, V. & Ferber, J. R. Maternal exposure to angiotensin converting enzyme inhibitors in the first trimester and risk of malformations in offspring: a retrospective cohort study. BMJ 343, d5931 (2011).
Google ScholarÂ
HĂźnseler, C. et al. Angiotensin II receptor blocker induced fetopathy: 7 cases. Klin. Pädiatr. 223, 10â14 (2011).
Google ScholarÂ
Mosley, J. F., Smith, L., Everton, E. & Fellner, C. Sodium-glucose linked transporter 2 (SGLT2) inhibitors in the management of type-2 diabetes: a drug class overview. Pharm. Ther. 40, 451â462 (2015).
Tangren, J. et al. Pre-Pregnancy eGFR and the risk of adverse maternal and fetal outcomes: a population-based study. J. Am. Soc. Nephrol. 34, 656â667 (2023).
Google ScholarÂ
Bramham, K. Diabetic nephropathy and pregnancy. Semin. Nephrol. 37, 362â369 (2017).
Google ScholarÂ
Al Khalaf, S. et al. Impact of chronic hypertension and antihypertensive treatment on adverse perinatal outcomes: systematic review and meta-analysis. J. Am. Heart Assoc. 10, e018494 (2021).
Google ScholarÂ
Wiles, K. et al. The impact of chronic kidney disease stages 3â5 on pregnancy outcomes. Nephrol. Dial. Transpl. 36, 2008â2017 (2021).
Google ScholarÂ
Piccoli, G. B. et al. Risk of adverse pregnancy outcomes in women with CKD. J. Am. Soc. Nephrol. 26, 2011â2022 (2015).
Google ScholarÂ
EMA recommends additional measures to prevent use of mycophenolate in pregnancy. 2015. Available: (2015).
Damkier, P., Passier, A., Bo Petersen, L., Havnen, G. & Thestrup Pedersen, A. J. Changing of the guards: EMA warning on paternal use of mycophenolate mofetil: an unnecessary and insufficiently substantiated precaution. Birth Defects Res. A Clin. Mol. Teratol. 106, 860â861 (2016).
Google ScholarÂ
Midtvedt, K., Bergan, S., ReisĂŚter, A. V., Vikse, B. E. & Ă sberg, A. Exposure to mycophenolate and fatherhood. Transplantation 101, e214âe217 (2017).
Google ScholarÂ
Le, H. L. et al. Usage of tacrolimus and mycophenolic acid during conception, pregnancy, and lactation, and its implications for therapeutic drug monitoring: a systematic critical review. Ther. Drug. Monit. 42, 518â531 (2020).
Google ScholarÂ
Boyer, A. et al. Paternity in male kidney transplant recipients: a French national survey, the PATeRNAL study. BMC Nephrol. 21, 483 (2020).
Google ScholarÂ
Jesudason, S. et al. Fatherhood and kidney replacement therapy: analysis of the Australian and New Zealand dialysis and transplant (ANZDATA) registry. Am. J. Kidney Dis. 76, 444â446 (2020).
Google ScholarÂ
Jones, D. C. & Hayslett, J. P. Outcome of pregnancy in women with moderate or severe renal insufficiency. N. Engl. J. Med. 335, 226â232 (1996).
Google ScholarÂ
Bramham, K. et al. Pregnancy outcome in women with chronic kidney disease: a prospective cohort study. Reprod. Sci. 18, 623â630 (2011).
Google ScholarÂ
Bramham, K. et al. Diagnostic and predictive biomarkers for pre-eclampsia in patients with established hypertension and chronic kidney disease. Kidney Int. 89, 874â885 (2016).
Google ScholarÂ
He, Y. et al. The pregnancy outcomes in patients with stage 3â4 chronic kidney disease and the effects of pregnancy in the long-term kidney function. J. Nephrol. 31, 953â960 (2018).
Google ScholarÂ
Reynolds, M. L. et al. Pregnancy history and kidney disease progression among women enrolled in cure glomerulonephropathy. Kidney Int. Rep. 8, 805â817 (2023).
Google ScholarÂ
Major, R. W. et al. The Kidney Failure Risk Equation for prediction of end stage renal disease in UK primary care: an external validation and clinical impact projection cohort study. PLoS Med. 16, e1002955 (2019).
Google ScholarÂ
Ralston, E. et al. POS-234 pregnancy-associated progression of chronic kidney disease: development of a clinical predictive tool. Kidney Int. Rep. 6, S99 (2021).
Google ScholarÂ
Ralston, E. et al. Pregnancy-associated progression of chronic kidney disease: a study protocol for the development and validation of a clinical predictive tool (PREDICT). J. Nephrol. 3, 773â776 (2024).
Smith, P. et al. ORCHARD: a model for conducting pragmatic randomised trials in pregnancy. J. Nephrol. 37, 1411â1413 (2024).
Webb, A. J. et al. Acute blood pressure lowering, vasoprotective, and antiplatelet properties of dietary nitrate via bioconversion to nitrite. Hypertension 51, 784â790 (2008).
Google ScholarÂ
Kemmner, S. et al. Dietary nitrate load lowers blood pressure and renal resistive index in patients with chronic kidney disease: a pilot study. Nitric Oxide Biol. Chem. 64, 7â15 (2017).
Google ScholarÂ
Ormesher, L. et al. Effects of dietary nitrate supplementation, from beetroot juice, on blood pressure in hypertensive pregnant women: a randomised, double-blind, placebo-controlled feasibility trial. Nitric Oxide 80, 37â44 (2018).
Google ScholarÂ
ORCHARD: Study to prevent progression of kidney disease in pregnancy. https://www.isrctn.com/ISRCTN91211980.
Cabiddu, G. et al. A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy. J. Nephrol. 29, 277â303 (2016).
Google ScholarÂ
Jong, M. F. C., de, Hamersvelt, H. W., van, Empel, I. W. H., van, Nijkamp, E. J. W. & Lely, A. T. Summary of the Dutch practice guideline on pregnancy wish and pregnancy in CKD. Kidney Int. Rep. 7, 2575â2588 (2022).
Google ScholarÂ
Henderson, J. T. et al. Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force. Ann. Intern. Med. 160, 695â703 (2014).
Google ScholarÂ
Rolnik, D. L. et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N. Engl. J. Med. 377, 613â622 (2017).
Google ScholarÂ
Gordon, C. et al. The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults. Rheumatol. Oxf. Engl. 57, e1âe45 (2018).
Google ScholarÂ
Izmirly, P. M. et al. Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine. Ann. Rheum. Dis. 69, 1827â1830 (2010).
Google ScholarÂ
Barsalou, J. et al. Prenatal exposure to antimalarials decreases the risk of cardiac but not non-cardiac neonatal lupus: a single-centre cohort study. Rheumatol. Oxf. Engl. 56, 1552â1559 (2017).
Google ScholarÂ
Derdulska, J. M. et al. Neonatal lupus erythematosus â practical guidelines. J. Perinat. Med. 49, 529â538 (2021).
Google ScholarÂ
Ahn, H. K. et al. Exposure to amlodipine in the first trimester of pregnancy and during breastfeeding. Hypertens. Pregnancy 26, 179â187 (2007).
Google ScholarÂ
Mito, A. et al. Safety of amlodipine in early pregnancy. J. Am. Heart Assoc. 8, e012093 (2019).
Google ScholarÂ
Ishikawa, T. et al. Risk of major congenital malformations associated with first-trimester antihypertensives, including amlodipine and methyldopa: a large claims database study 2010â2019. Pregnancy Hypertens. 31, 73â83 (2023).
Google ScholarÂ
Benachi, A. et al. Down syndrome maternal serum screening in patients with renal disease. Am. J. Obstet. Gynecol. 203, 60.e1âe4 (2010).
Google ScholarÂ
Valentin, M. et al. First-trimester combined screening for trisomy 21 in women with renal disease. Prenat. Diagn. 35, 244â248 (2015).
Google ScholarÂ
Qureshi, H. et al. BCSH guideline for the use of anti-D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn. Transfus. Med. Oxf. Engl. 24, 8â20 (2014).
Google ScholarÂ
National Institute for Health and Care Excellence. Antenatal Care [NICE Guideline No. 201] (2021).
Nevis, I. F. et al. Pregnancy outcomes in women with chronic kidney disease: a systematic review. Clin. J. Am. Soc. Nephrol. 6, 2587â2598 (2011).
Google ScholarÂ
Zhang, J. J. et al. A systematic review and meta-analysis of outcomes of pregnancy in CKD and CKD outcomes in pregnancy. Clin. J. Am. Soc. Nephrol. 10, 1964â1978 (2015).
Google ScholarÂ
NICE guideline. Hypertension in pregnancy: diagnosis and management. Am. J. Obstet. Gynecol. 77, S1âS22 (2019).
Oliverio, A. L. & Hladunewich, M. A. End stage kidney disease and dialysis in pregnancy. Adv. Chronic Kidney Dis. 27, 477â485 (2020).
Google ScholarÂ
Hou, S. H. Frequency and outcome of pregnancy in women on dialysis. Am. J. Kidney Dis. 23, 60â63 (1994).
Google ScholarÂ
Bagon, J. A. et al. Pregnancy and dialysis. Am. J. Kidney Dis. 31, 756 (1998).
Google ScholarÂ
Basok, E. K. et al. Assessment of female sexual function and quality of life in predialysis, peritoneal dialysis, hemodialysis, and renal transplant patients. Int. Urol. Nephrol. 41, 473â481 (2009).
Google ScholarÂ
Matuszkiewicz-Rowinska, J. et al. Endometrial morphology and pituitary-gonadal axis dysfunction in women of reproductive age undergoing chronic haemodialysis â a multicentre study. Nephrol. Dial. Transpl. 19, 2074â2077 (2004).
Google ScholarÂ
Hosfield, E. M., Rabban, J. T., Chen, L. M. & Zaloudek, C. J. Squamous metaplasia of the ovarian surface epithelium and subsurface fibrosis: distinctive pathologic findings in the ovaries and fallopian tubes of patients on peritoneal dialysis. Int. J. Gynecol. Pathol. 27, 465â474 (2008).
Google ScholarÂ
Confortini, P. et al. Full term successful pregnancy and successful delivery in a patient on chronic haemodialysis. Proc. Eur. Dial. Transpl. Assoc. 8, 74â80 (1971).
Piccoli, G. B. et al. Pregnancy in dialysis patients in the new millennium: a systematic review and meta-regression analysis correlating dialysis schedules and pregnancy outcomes. Nephrol. Dial. Transplant. 31, 1915â1934 (2016).
Google ScholarÂ
Baouche, H. et al. Pregnancy in women on chronic dialysis in the last decade (2010â2020): a systematic review. Clin. Kidney J. 16, 138â150 (2023).
Google ScholarÂ
Hladunewich, M. A. et al. Intensive hemodialysis associates with improved pregnancy outcomes: a Canadian and United States cohort comparison. J. Am. Soc. Nephrol. 25, 1103â1109 (2014).
Google ScholarÂ
Luders, C., Titan, S. M., Kahhale, S., Francisco, R. P. & Zugaib, M. Risk factors for adverse fetal outcome in hemodialysis pregnant women. Kidney Int. Rep. 3, 1077â1088 (2018).
Google ScholarÂ
Bramham, K. et al. Pregnancy in renal transplant recipients: a UK national cohort study. Clin. J. Am. Soc. Nephrol. 8, 290â298 (2013).
Google ScholarÂ
Chappell, L. C., Cluver, C. A., Kingdom, J. & Tong, S. Pre-eclampsia. Lancet 398, 341â354 (2021).
Google ScholarÂ
Tan, M. Y. et al. Screening for pre-eclampsia by maternal factors and biomarkers at 11â13 weeksâ gestation. Ultrasound Obstet. Gynecol. 52, 186â195 (2018).
Google ScholarÂ
Chappell, L. C. et al. Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study. Circulation 128, 2121â2131 (2013).
Google ScholarÂ
Duhig, K. E. et al. Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial. Lancet 393, 1807â1818 (2019).
Google ScholarÂ
Cerdeira, A. S. et al. Randomized interventional study on prediction of preeclampsia/eclampsia in women with suspected preeclampsia: INSPIRE. Hypertension 74, 983â990 (2019).
Google ScholarÂ
Wiles, K. et al. Placental and endothelial biomarkers for the prediction of superimposed pre-eclampsia in chronic kidney disease. Pregnancy Hypertens. 24, 58â64 (2021).
Google ScholarÂ
Gupta, M., Feinberg, B. B. & Burwick, R. M. Thrombotic microangiopathies of pregnancy: differential diagnosis. Pregnancy Hypertens. 12, 29â34 (2018).
Google ScholarÂ
Moroni, G., Calatroni, M., Donato, B. & Ponticelli, C. Kidney biopsy in pregnant women with glomerular diseases: focus on lupus nephritis. J. Clin. Med. 12, 1834 (2023).
Google ScholarÂ
Harel, Z. et al. Serum creatinine levels before, during, and after pregnancy. JAMA 321, 205â207 (2019).
Google ScholarÂ
Machado S et al. Acute kidney injury in pregnancy: a clinical challenge. J. Nephrol. 25, 19â30 (2012).
Google ScholarÂ
Wiles, K. et al. Serum creatinine in pregnancy: a systematic review. Kidney Int. Rep. 4, 408â419 (2018).
Google ScholarÂ
Gama, R. M. et al. Acute kidney injury e-alerts in pregnancy: rates, recognition and recovery. Nephrol. Dial. Transpl. 36, 1023â1030 (2021).
Google ScholarÂ
Conti-Ramsden, F. I. et al. Pregnancy-related acute kidney injury in preeclampsia: risk factors and renal outcomes. Hypertension 74, 1144â1151 (2019).
Google ScholarÂ
Noble, R. A., Lucas, B. J. & Selby, N. M. Long-term outcomes in patients with acute kidney injury. Clin. J. Am. Soc. Nephrol. 15, 423â429 (2020).
Google ScholarÂ
Ciciu, E., Paᚣatu-Cornea, A. M., Petcu, L. C. & TuĹŁÄ, L. A. Early diagnosis and management of maternal ureterohydronephrosis during pregnancy. Exp. Ther. Med. 23, 27 (2022).
Google ScholarÂ
Denstedt, J. D. & Razvi, H. Management of urinary calculi during pregnancy. J. Urol. 148, 1072â1074 (1992).
Google ScholarÂ
Lee, J. Y. et al. Canadian Urological Association guideline: management of ureteral calculi â full-text. Can. Urol. Assoc. J. 15, E676âE690 (2021).
Google ScholarÂ
Clark, K. et al. WCN24-1183 Assessing kidney function in pregnancy: gestation specific centile reference ranges for serum creatinine, urea, cystatin c and beta-2-microglobulin. Kidney Int. Rep. 9, S435âS436 (2024).
Google ScholarÂ
Chu, C. D. et al. CKD awareness among US adults by future risk of kidney failure. Am. J. Kidney Dis. 76, 174â183 (2020).
Google ScholarÂ
Piccoli, G. B. et al. Adding creatinine to routine pregnancy tests: a decision tree for calculating the cost of identifying patients with CKD in pregnancy. Nephrol. Dial. Transpl. 38, 148â157 (2023).
Google ScholarÂ
Crump, C., Sundquist, J. & Sundquist, K. Preterm or early term birth and risk of autism. Pediatrics 148, e2020032300 (2021).
Google ScholarÂ
Wang, C., Geng, H., Liu, W. & Zhang, G. Prenatal, perinatal, and postnatal factors associated with autism: a meta-analysis. Medicine 96, e6696 (2017).
Google ScholarÂ
Wiles, K. S., Nelson-Piercy, C. & Bramham, K. Reproductive health and pregnancy in women with chronic kidney disease. Nat. Rev. Nephrol. 14, 165â184 (2018).
Google ScholarÂ
Ramakrishnan, A., Lee, L. J., Mitchell, L. E. & Agopian, A. J. Maternal hypertension during pregnancy and the risk of congenital heart defects in offspring: a systematic review and meta-analysis. Pediatr. Cardiol. 36, 1442 (2015).
Google ScholarÂ
van Gelder, M. M. H. J. et al. Maternal hypertensive disorders, antihypertensive medication use, and the risk of birth defects: a case-control study. BJOG 122, 1002â1009 (2015).
Google ScholarÂ
Magee, L. A. et al. Less-tight versus tight control of hypertension in pregnancy. N. Engl. J. Med. 372, 407â417 (2015).
Google ScholarÂ
At, T. et al. Treatment for mild chronic hypertension during pregnancy. N. Engl. J. Med. 386, 1781â1792.
Luyckx, V. A. & Chevalier, R. L. Impact of early life development on later onset chronic kidney disease and hypertension and the role of evolutionary trade-offs. Exp. Physiol. 107, 410â414 (2022).
Google ScholarÂ
Hughson, M., Farris, A. B., Douglas-Denton, R., Hoy, W. E. & Bertram, J. F. Glomerular number and size in autopsy kidneys: the relationship to birth weight. Kidney Int. 63, 2113â2122 (2003).
Google ScholarÂ
Sutherland, M. R. & Black, M. J. The impact of intrauterine growth restriction and prematurity on nephron endowment. Nat. Rev. Nephrol. 19, 218â228 (2023).
Google ScholarÂ
Stonestreet, B. S., Hansen, N. B., Laptook, A. R. & Oh, W. Glucocorticoid accelerates renal functional maturation in fetal lambs. Early Hum. Dev. 8, 331â341 (1983).
Google ScholarÂ
Leeson, C. P. M., Kattenhorn, M., Morley, R., Lucas, A. & Deanfield, J. E. Impact of low birth weight and cardiovascular risk factors on endothelial function in early adult life. Circulation 103, 1264â1268 (2001).
Google ScholarÂ
Cwiek, A. et al. Premature differentiation of nephron progenitor cell and dysregulation of gene pathways critical to kidney development in a model of preterm birth. Sci. Rep. 11, 21667 (2021).
Google ScholarÂ
Warrington, N. M. et al. Maternal and fetal genetic effects on birth weight and their relevance to cardio-metabolic risk factors. Nat. Genet. 51, 804â814 (2019).
Google ScholarÂ
Grillo, M. A., Mariani, G. & Ferraris, J. R. Prematurity and low birth weight in neonates as a risk factor for obesity, hypertension, and chronic kidney disease in pediatric and adult age. Front. Med. 8, 769734 (2021).
Google ScholarÂ
Kelsey, T. W. et al. Ovarian volume throughout life: a validated normative model. PLoS ONE 8, e71465 (2013).
Google ScholarÂ
Sharpe, R. M., McKinnell, C., Kivlin, C. & Fisher, J. S. Proliferation and functional maturation of Sertoli cells, and their relevance to disorders of testis function in adulthood. Reprod. Camb. Engl. 125, 769â784 (2003).
Google ScholarÂ
Ratcliffe, J. M., Gladen, B. C., Wilcox, A. J. & Herbst, A. L. Does early exposure to maternal smoking affect future fertility in adult males? Reprod. Toxicol. Elmsford N. 6, 297â307 (1992).
Google ScholarÂ
Jensen, T. K. et al. Adult and prenatal exposures to tobacco smoke as risk indicators of fertility among 430 Danish couples. Am. J. Epidemiol. 148, 992â997 (1998).
Google ScholarÂ
Storgaard, L. et al. Does smoking during pregnancy affect sonsâ sperm counts? Epidemiol. Camb. Mass. 14, 278â286 (2003).
Google ScholarÂ
Jensen, T. K. et al. Association of in utero exposure to maternal smoking with reduced semen quality and testis size in adulthood: a cross-sectional study of 1,770 young men from the general population in five European countries. Am. J. Epidemiol. 159, 49â58 (2004).
Google ScholarÂ
Juul, A. et al. Possible fetal determinants of male infertility. Nat. Rev. Endocrinol. 10, 553â562 (2014).
Google ScholarÂ
Hildebrandt, F. Genetic kidney diseases. Lancet 375, 1287â1295 (2010).
Google ScholarÂ
Torra, R., Furlano, M., Ortiz, A. & Ars, E. Genetic kidney diseases as an underrecognized cause of chronic kidney disease: the key role of international registry reports. Clin. Kidney J. 14, 1879â1885 (2021).
Google ScholarÂ
Connaughton, D. M. et al. The Irish kidney gene project â prevalence of family history in patients with kidney disease in Ireland. Nephron 130, 293â301 (2015).
Google ScholarÂ
Thakoordeen-Reddy, S. et al. Maternal variants within the apolipoprotein L1 gene are associated with preeclampsia in a South African cohort of African ancestry. Eur. J. Obstet. Gynecol. Reprod. Biol. 246, 129â133 (2020).
Google ScholarÂ
Reidy, K. J. et al. Fetal â not maternal â APOL1 genotype associated with risk for preeclampsia in those with African ancestry. Am. J. Hum. Genet. 103, 367â376 (2018).
Google ScholarÂ
Sampson, M. G. et al. Integrative genomics identifies novel associations with APOL1 risk genotypes in Black Neptune subjects. J. Am. Soc. Nephrol. 27, 814â823 (2016).
Google ScholarÂ
Moxey-Mims, M. Kidney disease in African American children: biological and nonbiological disparities. Am. J. Kidney Dis. 72, S17âS21 (2018).
Google ScholarÂ
Coscia, L. A. et al. Update on the teratogenicity of maternal mycophenolate mofetil. J. Pediatr. Genet. 4, 42â55 (2015).
Google ScholarÂ
Pham-Huy, A. et al. From mother to baby: antenatal exposure to monoclonal antibody biologics. Expert. Rev. Clin. Immunol. 15, 221â229 (2019).
Google ScholarÂ
Committee on Infectious Diseases AA of P, Kimberlin, D. W., Barnett, E. D., Lynfield, R., Sawyer, M. H. (eds). Immunization in Special Clinical Circumstances. In: Red Book: 2021â2024 Report of the Committee on Infectious Diseases [Internet]. American Academy of Pediatrics, (2021) [cited 2024 Oct 22]. p. 0. Available from: https://doi.org/10.1542/9781610025782.
Hallstensen, R. F. et al. Eculizumab treatment during pregnancy does not affect the complement system activity of the newborn. Immunobiology 220, 452â459 (2015).
Google ScholarÂ
Kramer, M. S. & Kakuma, R. Optimal duration of exclusive breastfeeding. Cochrane Database Syst. Rev. 2012, CD003517 (2012).
Google ScholarÂ
Kramer M. S. & Kakuma R. in Protecting Infants through Human Milk. (eds Pickering L. K., Morrow A. L., Ruiz-Palacios G. M. & Schanler R.J.) Advances in Experimental Medicine and Biology. 63â77 (Springer, 2004).
Stuebe, A. M., Rich-Edwards, J. W., Willett, W. C., Manson, J. E. & Michels, K. B. Duration of lactation and incidence of type 2 diabetes. JAMA 294, 2601â2610 (2005).
Google ScholarÂ
Rød, B. E., Torkildsen, Ă., Myhr, K.-M., Bø, L. & Wergeland, S. Safety of breast feeding during rituximab treatment in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 94, 38 (2023).
Google ScholarÂ
Stefanovic, V. The extended use of eculizumab in pregnancy and complement activationâassociated diseases affecting maternal, fetal and neonatal kidneys â the future is now? J. Clin. Med. 8, 407 (2019).
Google ScholarÂ
APILAM. [cited 2024 May 30]. http://e-lactancia.org/privacidad/.
Eisenberg, M. L., Li, S., Cullen, M. R. & Baker, L. C. Increased risk of incident chronic medical conditions in infertile men: analysis of United States claims data. Fertil. Steril. 105, 629â636 (2016).
Google ScholarÂ
Kitlinski, M., Giwercman, A., Christensson, A., Nilsson, P. M. & Elenkov, A. Prevalence of impaired renal function among childless men as compared to fathers: a population-based study. Sci. Rep. 14, 7720 (2024).
Google ScholarÂ
Imbasciati, E. et al. Pregnancy in CKD stages 3 to 5: fetal and maternal outcomes. Am. J. Kidney Dis. 49, 753â762 (2007).
Google ScholarÂ
Gouveia, I. F., Silva, J. R., Santos, C. & Carvalho, C. Maternal and fetal outcomes of pregnancy in chronic kidney disease: diagnostic challenges, surveillance and treatment throughout the spectrum of kidney disease. J. Bras. Nefrol. 43, 88â102 (2021).
Google ScholarÂ
Bramham, K. Pregnancy in renal transplant recipients and donors. Semin. Nephrol. 37, 370â377 (2017).
Google ScholarÂ
Banerjee, I. et al. Health outcomes of children born to mothers with chronic kidney disease: a pilot study. Pediatr. Rep. 2, 22â25 (2010).
Google ScholarÂ
Abou-Jaoude, P. et al. What about the renal function during childhood of children born from dialysed mothers? Nephrol. Dial. Transpl. 27, 2365â2369 (2012).
Google ScholarÂ
Blowey, D. L. & Warady, B. A. Outcome of infants born to women with chronic kidney disease. Adv. Chronic Kidney Dis. 14, 199â205 (2007).
Google ScholarÂ
Tong, A., Brown, M. A., Winkelmayer, W. C., Craig, J. C. & Jesudason, S. Perspectives on pregnancy in women with CKD: a semistructured interview study. Am. J. Kidney Dis. 66, 951â961 (2015).
Google ScholarÂ
Ralston, E. R., Smith, P., Chilcot, J., Silverio, S. A. & Bramham, K. Perceptions of risk in pregnancy with chronic disease: a systematic review and thematic synthesis. PLoS ONE 16, e0254956 (2021).
Google ScholarÂ
Scherzer, A. L., Chhagan, M., Kauchali, S. & Susser, E. Global perspective on early diagnosis and intervention for children with developmental delays and disabilities. Dev. Med. Child. Neurol. 54, 1079â1084 (2012).
Google ScholarÂ
Bateman, B. T. et al. Late pregnancy β blocker exposure and risks of neonatal hypoglycemia and bradycardia. Pediatrics 138, e20160731 (2016).
Google ScholarÂ
Morgan, J. L. et al. Pharmacokinetics of amlodipine besylate at delivery and during lactation. Pregnancy Hypertens. 11, 77â80 (2018).
Google ScholarÂ
Xie, R. H. et al. Beta-blockers increase the risk of being born small for gestational age or of being institutionalised during infancy. BJOG 121, 1090â1096 (2014).
Google ScholarÂ
Magee L. A., Duley L. Oral beta-blockers for mild to moderate hypertension during pregnancy. Cochrane Database Syst. Rev. 2003, CD002863 (2000).
Google ScholarÂ
Nice, F. J. & Luo, A. C. Medications and breast-feeding: current concepts. J. Am. Pharm. Assoc. 52, 86â94 (2012).
Google ScholarÂ
National Collaborating Centre for Womenâs and Childrenâs Health (UK). Hypertension in Pregnancy: The Management of Hypertensive Disorders During Pregnancy (RCOG Press, 2010).
Ornoy, A. Pharmacological treatment of attention deficit hyperactivity disorder during pregnancy and lactation. Pharm. Res. 35, 46 (2018).
Google ScholarÂ
Schreiber, K. et al. British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: comorbidity medications used in rheumatology practice. Rheumatology 62, e89âe104 (2023).
Google ScholarÂ
Sau, A. et al. Azathioprine and breastfeeding: is it safe? BJOG 114, 498â501 (2007).
Google ScholarÂ
Bramham, K., Chusney, G., Lee, J., Lightstone, L. & Nelson-Piercy, C. Breastfeeding and tacrolimus: serial monitoring in breast-fed and bottle-fed infants. Clin. J. Am. Soc. Nephrol. 8, 563 (2013).
Google ScholarÂ
Muller, D. R. P. et al. Effects of GLP-1 agonists and SGLT2 inhibitors during pregnancy and lactation on offspring outcomes: a systematic review of the evidence. Front. Endocrinol. 14 (2023).
World Health Organization. Breastfeeding and maternal medication: recommendations for drugs in the eleventh WHO model list of essential drugs. (2002).
Clark, S. L., Porter, T. F. & West, F. G. Coumarin derivatives and breast-feeding. Obstet. Gynecol. 95, 938â940 (2000).
Google ScholarÂ
link
